204 related articles for article (PubMed ID: 35621727)
1. Gadolinium-based contrast agent attenuation does not impact PET quantification in simultaneous dynamic contrast enhanced breast PET/MR.
Allen TJ; Henze Bancroft LC; Kumar M; Bradshaw TJ; Strigel RM; McMillan AB; Fowler AM
Med Phys; 2022 Aug; 49(8):5206-5215. PubMed ID: 35621727
[TBL] [Abstract][Full Text] [Related]
2. Ferumoxytol Does Not Impact Standardized Uptake Values on PET/MR Scans.
Muehe AM; Yerneni K; Theruvath AJ; Thakor AS; Pribnow A; Avedian R; Steffner R; Rosenberg J; Hawk KE; Daldrup-Link HE
Mol Imaging Biol; 2020 Jun; 22(3):722-729. PubMed ID: 31325083
[TBL] [Abstract][Full Text] [Related]
3. Potential influence of Gadolinium contrast on image segmentation in MR-based attenuation correction with Dixon sequences in whole-body 18F-FDG PET/MR.
Ruhlmann V; Heusch P; Kühl H; Beiderwellen K; Antoch G; Forsting M; Bockisch A; Buchbender C; Quick HH
MAGMA; 2016 Apr; 29(2):301-8. PubMed ID: 26667965
[TBL] [Abstract][Full Text] [Related]
4. Hybrid PET- and MR-driven attenuation correction for enhanced
Karakatsanis NA; Abgral R; Trivieri MG; Dweck MR; Robson PM; Calcagno C; Boeykens G; Senders ML; Mulder WJM; Tsoumpas C; Fayad ZA
J Nucl Cardiol; 2020 Aug; 27(4):1126-1141. PubMed ID: 31667675
[TBL] [Abstract][Full Text] [Related]
5. Reliability of
Jena A; Taneja S; Singh A; Negi P; Sarin R; Das PK; Singhal M
AJR Am J Roentgenol; 2017 Sep; 209(3):662-670. PubMed ID: 28678576
[TBL] [Abstract][Full Text] [Related]
6. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
Williams JM; Rani SD; Li X; Arlinghaus LR; Lee TC; MacDonald LR; Partridge SC; Kang H; Whisenant JG; Abramson RG; Linden HM; Kinahan PE; Yankeelov TE
Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
[TBL] [Abstract][Full Text] [Related]
7. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
[TBL] [Abstract][Full Text] [Related]
8. A 16-channel MR coil for simultaneous PET/MR imaging in breast cancer.
Dregely I; Lanz T; Metz S; Mueller MF; Kuschan M; Nimbalkar M; Bundschuh RA; Ziegler SI; Haase A; Nekolla SG; Schwaiger M
Eur Radiol; 2015 Apr; 25(4):1154-61. PubMed ID: 25287263
[TBL] [Abstract][Full Text] [Related]
9. Measuring Glucose Uptake in Primary Invasive Breast Cancer Using Simultaneous Time-of-Flight Breast PET/MRI: A Method Comparison Study with Prone PET/CT.
Fowler AM; Kumar M; Bancroft LH; Salem K; Johnson JM; Karow J; Perlman SB; Bradshaw TJ; Hurley SA; McMillan AB; Strigel RM
Radiol Imaging Cancer; 2021 Jan; 3(1):e200091. PubMed ID: 33575660
[TBL] [Abstract][Full Text] [Related]
10. Preliminary analysis: Background parenchymal 18F-FDG uptake in breast cancer patients appears to correlate with background parenchymal enhancement and to vary by distance from the index cancer.
Kim E; Mema E; Axelrod D; Sigmund E; Kim SG; Babb J; Melsaether AN
Eur J Radiol; 2019 Jan; 110():163-168. PubMed ID: 30599855
[TBL] [Abstract][Full Text] [Related]
11. Attenuation correction and truncation completion for breast PET/MR imaging using deep learning.
Li X; Johnson JM; Strigel RM; Bancroft LCH; Hurley SA; Estakhraji SIZ; Kumar M; Fowler AM; McMillan AB
Phys Med Biol; 2024 Feb; 69(4):. PubMed ID: 38252969
[No Abstract] [Full Text] [Related]
12. An experimental phantom study of the effect of gadolinium-based MR contrast agents on PET attenuation coefficients and PET quantification in PET-MR imaging: application to cardiac studies.
O' Doherty J; Schleyer P
EJNMMI Phys; 2017 Dec; 4(1):4. PubMed ID: 28084612
[TBL] [Abstract][Full Text] [Related]
13. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C
J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481
[TBL] [Abstract][Full Text] [Related]
14. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA
Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
[TBL] [Abstract][Full Text] [Related]
15. Comparison of standardized uptake values in normal structures between PET/CT and PET/MRI in an oncology patient population.
Kershah S; Partovi S; Traughber BJ; Muzic RF; Schluchter MD; O'Donnell JK; Faulhaber P
Mol Imaging Biol; 2013 Dec; 15(6):776-85. PubMed ID: 23632951
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Dixon Sequence on Hybrid PET/MR Compared with Contrast-Enhanced PET/CT for PET-Positive Lesions.
Jeong JH; Cho IH; Kong EJ; Chun KA
Nucl Med Mol Imaging; 2014 Mar; 48(1):26-32. PubMed ID: 24900135
[TBL] [Abstract][Full Text] [Related]
17. Combined PET/MR imaging in neurology: MR-based attenuation correction implies a strong spatial bias when ignoring bone.
Andersen FL; Ladefoged CN; Beyer T; Keller SH; Hansen AE; Højgaard L; Kjær A; Law I; Holm S
Neuroimage; 2014 Jan; 84():206-16. PubMed ID: 23994317
[TBL] [Abstract][Full Text] [Related]
18. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
19. Hybrid ZTE/Dixon MR-based attenuation correction for quantitative uptake estimation of pelvic lesions in PET/MRI.
Leynes AP; Yang J; Shanbhag DD; Kaushik SS; Seo Y; Hope TA; Wiesinger F; Larson PE
Med Phys; 2017 Mar; 44(3):902-913. PubMed ID: 28112410
[TBL] [Abstract][Full Text] [Related]
20. Whole-body PET/MRI: the effect of bone attenuation during MR-based attenuation correction in oncology imaging.
Aznar MC; Sersar R; Saabye J; Ladefoged CN; Andersen FL; Rasmussen JH; Löfgren J; Beyer T
Eur J Radiol; 2014 Jul; 83(7):1177-1183. PubMed ID: 24780817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
